Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_137cc82ecdde37478e925e83839044fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3eead6cc90c4abe2222c83750868c8e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cb5ac54ad6d12d3813fdf0320029338 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6ee7a057f4612263abc96fc3412d2cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43edc4811074353baaa68d8f129033e2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74 |
filingDate |
2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68aa21ca5c3cad787604150572716f0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0061797375f34206a073f17a807a2490 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74e36cec93eddd4c611cd4fdf7bab171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db246064a7a70af21578a9e2ece0ba5 |
publicationDate |
2002-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0174848-A3 |
titleOfInvention |
Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
abstract |
The present invention is directed to the treatment of autoimmune diseases, in particular of Myasthenia Gravis. This invention provides novel autoimmune dominant peptides derived from the acetylcholine receptor, as well as methods for preparing the peptides. The present invention further provides complexes comprising these peptides associated with an appropriate major histocompatibility complex (MHC) molecule and methods for making these complexes. The complexes of the present invention can be used therapeutically or prophylactically for treating Myasthenia Gravis. |
priorityDate |
2000-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |